Home
All Products
Browse everything Collectibles Kitchen Home Tech Gaming Beauty Fitness Pets Fashion Travel Kids Food Outdoor Auto Throwback
Gift Guides Viral Hits by Decade
CeraVe Moisturizer
CeraVe (L'Oréal)

CeraVe Moisturizer

🔥 HOT

A dermatologist-developed drugstore moisturizer that went from a modest $140 million brand to a TikTok-driven skincare phenomenon almost overnight.

CeraVe is a mass-market skincare line built around ceramides and a straightforward, dermatologist-endorsed formula — the kind of product that spent over a decade as a quiet pharmacy staple before an entirely unplanned wave of Gen Z social media attention turned it into one of the biggest skincare brands in the world.

82%
like-for-like sales growth in a single nine-month stretch during CeraVe's TikTok breakout
359%
peak spike in CeraVe search volume in June 2020, versus 38% for the rest of the skincare category
$140M → $600M+
estimated annual revenue growth in roughly two years during the brand's viral surge

A 15-year-old dermatologist brand, not a new one

CeraVe was co-developed with dermatologists specifically to treat dry skin, and had been sold for well over a decade before its viral moment — this wasn't a new product capitalizing on a trend, but an established, clinically credible one that got discovered by an audience that hadn't been paying attention.

The catalyst was largely Gen Z skincare creators on TikTok (Hyram Yarbro chief among them) recommending it specifically for its no-frills, ingredient-first approach at a moment when younger skincare consumers were turning away from prestige packaging and toward dermatologist-backed formulas.

Turning a viral spike into sustained growth

L'Oréal, which owns CeraVe, has been explicit that the brand's growth wasn't a one-time spike: it posted 82% like-for-like sales growth over nine months during its breakout period, with demand strong enough that products sold out in some markets entirely.

CeraVe has stayed deliberately unchanged in strategy since — no move upmarket, no aspirational repositioning — which is itself now seen as the smarter long-term play: its clinical-credibility-at-a-drugstore-price identity is exactly what makes it hard for a rival to copy without also lowering its own prices.

You might also like